
Tirzepatide
Tirzepatide is a synthetic dual-agonist research peptide studied for its activity at the GLP-1 and GIP receptors.
This product is sold strictly for laboratory research purposes only. It is not intended for human or animal consumption, medical use, diagnostic use, therapeutic use, or personal use of any kind. By purchasing this product, the buyer represents that they are a qualified researcher, laboratory, institution, or entity purchasing solely for lawful research applications and buyer agrees to handle the material in compliance with all applicable laws and regulations. No claims are made regarding efficacy, safety, or suitability for any specific application.
Form: Lyophiled powder
Strength: 30mg
Intended Use: Laboratory research only
Regulatory Status: Not approved for human or animal use
Tirzepatide is studied for its dual incretin receptor activity at GLP-1 and GIP receptors. Research has examined its effects on metabolic signaling, glucose regulation, appetite-related pathways, and energy balance.